TrialClinical pharmacology and therapeutics2021

Quantitative Clinical Pharmacology Supports the Bridging From i.v. Dosing and Approval of s.c. Rituximab in B-Cell Hematological Malignancies.

Candice Jamois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.